Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
about
An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesisHRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRTEstrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.Body size from birth to middle age and the risk of hip and knee replacement.Is transdermal menopausal hormone therapy a safer option than oral therapy?Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohortUse of hormone replacement therapy and the risk of colorectal cancer.Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a prospective cohort study.What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.Are incident gallstones associated to sex-dependent changes with age? A cohort study.Diet and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort.Relationship between gallbladder surgery and ethnic admixture in African American and Hispanic American women.Fruit and vegetable consumption and risk of cholecystectomy: a prospective cohort study of women and men.Cholecystectomy and Diagnosis-Related Groups (DRGs): patient classification and hospital reimbursement in 11 European countries.Postmenopausal hormone replacement therapy and risk of cholecystectomy: a prospective cohort study.HRT and breast cancer: recent findings in the context of the evidence to date.An evidence-based future for menopausal hormone therapy.Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
P2860
Q27310177-55348BD5-3E3C-4221-B9D9-2BA6E0E86AA2Q28294446-A46C1F74-CDE9-41E2-AC1B-7691D9003840Q34093125-DCB8D170-9B36-463F-80CA-6D04DD973A09Q35035445-AF26785D-D6F9-4AA9-9F93-CFF43EA7C8AFQ36052234-089064F4-9EAD-450E-863E-8348FD16B0F3Q36767313-94AC9D62-79C0-4962-80A0-FBEC27CF523FQ36767319-C88F562C-22E5-4BEA-8CCD-090DDAF2B5D9Q37369812-4C5D1064-E32E-4CE4-9189-837B8624ACDCQ37641557-C705D3B7-90A2-4033-A4A7-E1BE1B9CCED4Q37995320-A4DD527B-1964-49E6-BFE0-1342C32937A2Q38658120-35722CA7-C85F-4F82-AC97-BDDABD284001Q38662855-BC19430E-ACB4-42C2-8C11-31CA1646093BQ39295211-B8369068-CA4E-4E5F-B379-CA539C1132F4Q39470237-144B03D4-CBEB-47C8-A52A-30E88BC28984Q43058137-1D58A33F-9DCD-42BB-AA20-C6DD30B9049AQ43680757-887C7A80-E811-480E-BAE9-1A4B2D078E57Q46203770-C5A3A73B-2B9C-4B99-A61B-9B2028D1083FQ48394923-C0E31A3C-2563-4DDC-AEC6-5287480A25FEQ50490968-E8FE7C60-07E7-4DA3-8E5E-5417DD6D47E3Q55060038-9155F864-710C-44FA-9792-1240C60DE68E
P2860
Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Gallbladder disease and use of ...... omen: prospective cohort study
@ast
Gallbladder disease and use of ...... omen: prospective cohort study
@en
type
label
Gallbladder disease and use of ...... omen: prospective cohort study
@ast
Gallbladder disease and use of ...... omen: prospective cohort study
@en
prefLabel
Gallbladder disease and use of ...... omen: prospective cohort study
@ast
Gallbladder disease and use of ...... omen: prospective cohort study
@en
P2860
P50
P356
P1433
P1476
Gallbladder disease and use of ...... omen: prospective cohort study
@en
P2093
Jane Green
Siân Sweetland
P2860
P356
10.1136/BMJ.A386
P407
P577
2008-07-10T00:00:00Z